John Maraganore insider trades
Open-market stock purchases and sales by John Maraganore, Unknown at Rapport Therapeutics, Inc, from SEC Form 4 filings since Aug 17, 2010.
Track record: 22% of 9 scored buys are up 5% or more since purchase, averaging -5%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 22, 2026 | RAPP Rapport Therapeutics, Inc | Bought | $217K |
| Oct 22, 2026 | RAPP Rapport Therapeutics, Inc | Bought | $31.5K |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 19, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Oct 15, 2026 | CTY City Therapeutics, Inc | Bought (not open market) | — |
| Jul 10, 2026 | TAK Takeda Pharmaceutical Co Ltd | Sold (not open market) | $5.7M |
| Jul 1, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
| Jul 1, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
| Jun 24, 2026 | KYMR Kymera Therapeutics, Inc | Bought (not open market) | — |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc | Bought (not open market) | — |
| Jun 3, 2026 | BEAM Beam Therapeutics Inc | Bought (not open market) | — |
| May 4, 2026 | COAG Hemab Therapeutics Holdings, Inc | Bought (not open market) | — |
| May 4, 2026 | COAG Hemab Therapeutics Holdings, Inc | Bought (not open market) | — |
| Jan 29, 2026 | COAG Hemab Therapeutics Holdings, Inc | Bought (not open market) | — |
Companies traded
- RAPP Rapport Therapeutics, Inc: 2 buys, last Oct 22, 2026
- CTY City Therapeutics, Inc: other filings, last Oct 19, 2026
- TAK Takeda Pharmaceutical Co Ltd: other filings, last Jul 10, 2026
- KYMR Kymera Therapeutics, Inc: other filings, last Jun 24, 2026
- BEAM Beam Therapeutics Inc: other filings, last Jun 3, 2026
- COAG Hemab Therapeutics Holdings, Inc: other filings, last May 4, 2026
- PROK Prokidney Corp: other filings, last Jun 29, 2023
- AGIO Agios Pharmaceuticals, Inc: 4 buys, 4 sales, last Jun 21, 2022
- ALNY Alnylam Pharmaceuticals, Inc: 6 buys, 121 sales, last Dec 22, 2021
- BLUE bluebird bio, Inc: 2 buys, 6 sales, last Sep 14, 2017
- ALKS Alnylam Pharmaceuticals, Inc: other filings, last Sep 11, 2013
- RGLS Regulus Therapeutics Inc: other filings, last Oct 10, 2012